|
COX7A2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.824160E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.357100E-04 |
| Normal-vs-Stage2 |
1.037660E-02 |
| Normal-vs-Stage3 |
4.780500E-03 |
| Normal-vs-Stage4 |
9.556200E-03 |
| Stage1-vs-Stage2 |
8.617800E-01 |
| Stage1-vs-Stage3 |
8.806400E-01 |
| Stage1-vs-Stage4 |
9.769200E-01 |
| Stage2-vs-Stage3 |
7.845000E-01 |
| Stage2-vs-Stage4 |
9.040600E-01 |
| Stage3-vs-Stage4 |
8.899200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.161140E-03 |
| Normal-vs-AfricanAmerican |
4.657600E-02 |
| Normal-vs-Asian |
1.987230E-04 |
| Caucasian-vs-AfricanAmerican |
8.283000E-01 |
| Caucasian-vs-Asian |
2.737800E-01 |
| AfricanAmerican-vs-Asian |
3.229200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.777900E-04 |
| Normal-vs-Female |
1.078920E-03 |
| Male-vs-Female |
3.862200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.164600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.563000E-03 |
| Normal-vs-Age(61-80Yrs) |
8.702600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.618200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.615000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.711200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.806400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.948200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.283400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.778400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.483000E-01 |
| Classical-VS-Follicular |
4.765000E-01 |
| Classical-VS-Other |
6.115400E-01 |
| Classical-VS-Normal |
3.386200E-04 |
| Tall-VS-Follicular |
7.084200E-01 |
| Tall-VS-Other |
4.739200E-01 |
| Tall-VS-Normal |
2.332300E-02 |
| Follicular-VS-Other |
4.903200E-01 |
| Follicular-VS-Normal |
5.874400E-02 |
| Other-VS-Normal |
1.742390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.062200E-03 |
| Normal-vs-N1 |
1.15450000004458E-06 |
| N0-vs-N1 |
1.343720E-02 |
|
|
